UB Paderborn / Katalog / Suche / in CDI

A Study of the Potential Interaction Between Bazedoxifene and Atorvastatin in Healthy Postmenopausal Women

Clinical pharmacology in drug development, 2018-11, Vol.7 (8), p.911-919

2018

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Safety of Bazedoxifene in Hepatically Impaired and Healthy Postmenopausal Women

Clinical pharmacology in drug development, 2018-05, Vol.7 (4), p.365-372

2018

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic Drug Interaction Study of Bazedoxifene and Ibuprofen

Clinical pharmacology in drug development, 2018-05, Vol.7 (4), p.358-364

2018

Link zum Volltext

Verfügbarkeit prüfen

Safety, Pharmacokinetics, and Pharmacodynamics of ASP3662, a Novel 11β‐Hydroxysteroid Dehydrogenase Type 1 Inhibitor, in Healthy Young and Elderly Subjects

Clinical and translational science, 2019-05, Vol.12 (3), p.291-301

2019

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Safety of a Single Intravenous Dose of the Antibiotic Tigecycline in Patients With Cirrhosis

Journal of clinical pharmacology, 2011-01, Vol.51 (1), p.93-101

2011

Link zum Volltext

Verfügbarkeit prüfen

An Open-Label, Single-Dose, Parallel-Group Study of the Effects of Chronic Hepatic Impairment on the Safety and Pharmacokinetics of Desvenlafaxine

Clinical therapeutics, 2013-06, Vol.35 (6), p.782-794

2013

Link zum Volltext

Verfügbarkeit prüfen

The effects of a single dose administration of SAM-531, a 5-HT6 antagonist, on sleep electroencephalogram (EEG) and quantitative wake EEG (qEEG) in healthy subjects

Alzheimer's & dementia, 2010-07, Vol.6 (4), p.S510-S510

2010

Link zum Volltext

Verfügbarkeit prüfen

CFTR activity is enhanced by the novel corrector GLPG2222, given with and without ivacaftor in two randomized trials

Journal of cystic fibrosis, 2019-09, Vol.18 (5), p.700-707

2019

Link zum Volltext

Verfügbarkeit prüfen

GLPG2737 in lumacaftor/ivacaftor-treated CF subjects homozygous for the F508del mutation: A randomized phase 2A trial (PELICAN)

Journal of cystic fibrosis, 2020-03, Vol.19 (2), p.292-298

2020

Link zum Volltext

Verfügbarkeit prüfen

Safety, Pharmacokinetics, and Pharmacodynamics of ASP 3662, a Novel 11β‐Hydroxysteroid Dehydrogenase Type 1 Inhibitor, in Healthy Young and Elderly Subjects

Clinical and translational science, 2019-05, Vol.12 (3), p.291-301

2019

Link zum Volltext

Verfügbarkeit prüfen

Imaging the Enzyme 11β-Hydroxysteroid Dehydrogenase Type 1 with PET: Evaluation of the Novel Radiotracer 11 C-AS2471907 in Human Brain

Journal of Nuclear Medicine, 2019-08, Vol.60 (8), p.1140-1146

2019

Link zum Volltext

Verfügbarkeit prüfen

Imaging the Enzyme 11β-Hydroxysteroid Dehydrogenase Type 1 with PET: Evaluation of the Novel Radiotracer 11C-AS2471907 in Human Brain

The Journal of nuclear medicine (1978), 2019-08, Vol.60 (8), p.1140-1146

2019

Link zum Volltext

Verfügbarkeit prüfen

Single- and multiple-dose safety, tolerability and pharmacokinetics of a Novel 5HT6 receptor full antagonist (SAM-760) for the treatment of the symptoms of Alzheimer's disease in healthy young adults and elderly subjects

Alzheimer's & dementia, 2011-07, Vol.7 (4), p.S778-S778

2011

Link zum Volltext

Verfügbarkeit prüfen

P4‐214: Single‐ and multiple‐dose safety, tolerability and pharmacokinetics of a Novel 5HT6 receptor full antagonist (SAM‐760) for the treatment of the symptoms of Alzheimer's disease in healthy young adults and elderly subjects

Alzheimer's & dementia, 2011-07, Vol.7 (4S_Part_22), p.S778-S778

2011

Link zum Volltext

Verfügbarkeit prüfen

P1‐445: Early evaluation of the safety, tolerability and pharmacokinetics of a novel 5HT6 receptor full antagonist for the treatment of the symptoms of mild‐to‐moderate dementia of the Alzheimer type

Alzheimer's & dementia, 2010-07, Vol.6 (4S_Part_10), p.S306-S307

2010

Link zum Volltext

Verfügbarkeit prüfen

Early evaluation of the safety, tolerability and pharmacokinetics of a novel 5HT6 receptor full antagonist for the treatment of the symptoms of mild-to-moderate dementia of the Alzheimer type

Alzheimer's & dementia, 2010-07, Vol.6 (4), p.S306-S307

2010

Link zum Volltext

Verfügbarkeit prüfen

P3‐203: The effects of a single dose administration of SAM‐531, a 5‐HT6 antagonist, on sleep electroencephalogram (EEG) and quantitative wake EEG (qEEG) in healthy subjects

Alzheimer's & dementia, 2010-07, Vol.6, p.S510-S510

2010

Link zum Volltext

Verfügbarkeit prüfen

P3‐203: The effects of a single dose administration of SAM‐531, a 5‐HT 6 antagonist, on sleep electroencephalogram (EEG) and quantitative wake EEG (qEEG) in healthy subjects

Alzheimer's & dementia, 2010-07, Vol.6 (4S_Part_17)

2010

Link zum Volltext

Verfügbarkeit prüfen

Lengthening Behavior of Magnetically Controlled Growing Rods in Early-Onset Scoliosis: A Multicenter Study

Journal of bone and joint surgery. American volume, 2022-12, Vol.104 (24), p.2186

2022

Link zum Volltext

Verfügbarkeit prüfen

The Effect of Surgeon Experience on Outcomes Following Growth Friendly Instrumentation for Early Onset Scoliosis

Journal of pediatric orthopaedics, 2022-02, Vol.42 (2), p.e132

2022

Link zum Volltext

Verfügbarkeit prüfen

Growth-friendly Spinal Instrumentation in Marfan Syndrome Achieves Sustained Gains in Thoracic Height Amidst High Rates of Implant Failure

Journal of pediatric orthopaedics, 2021-03, Vol.41 (3), p.e204

2021

Link zum Volltext

Verfügbarkeit prüfen

To tether or fuse? Significant equipoise remains in treatment recommendations for idiopathic scoliosis

Spine deformity, 2022-07, Vol.10 (4), p.763-773

2022

Link zum Volltext

Verfügbarkeit prüfen

The role of traditional growing rods in the era of magnetically controlled growing rods for the treatment of early-onset scoliosis

Spine deformity, 2021-09, Vol.9 (5), p.1465-1472

2021

Link zum Volltext

Verfügbarkeit prüfen

Low radius of curvature growth-friendly rib-based implants increase the risk of developing clinically significant proximal junctional kyphosis

Spine deformity, 2023-05, Vol.11 (3), p.733-738

2023

Link zum Volltext

Verfügbarkeit prüfen

Body mass index affects outcomes after vertebral body tethering surgery

Spine deformity, 2022-05, Vol.10 (3), p.563-571

2022

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

A Study of the Potential Interaction Between Bazedoxifene and Atorvastatin in Healthy Postmenopausal Women

Pharmacokinetics and Safety of Bazedoxifene in Hepatically Impaired and Healthy Postmenopausal Women

Pharmacokinetic Drug Interaction Study of Bazedoxifene and Ibuprofen

Safety, Pharmacokinetics, and Pharmacodynamics of ASP3662, a Novel 11β‐Hydroxysteroid Dehydrogenase Type 1 Inhibitor, in Healthy Young and Elderly Subjects

Pharmacokinetics and Safety of a Single Intravenous Dose of the Antibiotic Tigecycline in Patients With Cirrhosis

An Open-Label, Single-Dose, Parallel-Group Study of the Effects of Chronic Hepatic Impairment on the Safety and Pharmacokinetics of Desvenlafaxine

The effects of a single dose administration of SAM-531, a 5-HT6 antagonist, on sleep electroencephalogram (EEG) and quantitative wake EEG (qEEG) in healthy subjects

CFTR activity is enhanced by the novel corrector GLPG2222, given with and without ivacaftor in two randomized trials

GLPG2737 in lumacaftor/ivacaftor-treated CF subjects homozygous for the F508del mutation: A randomized phase 2A trial (PELICAN)

Safety, Pharmacokinetics, and Pharmacodynamics of ASP 3662, a Novel 11β‐Hydroxysteroid Dehydrogenase Type 1 Inhibitor, in Healthy Young and Elderly Subjects

Imaging the Enzyme 11β-Hydroxysteroid Dehydrogenase Type 1 with PET: Evaluation of the Novel Radiotracer 11 C-AS2471907 in Human Brain

Imaging the Enzyme 11β-Hydroxysteroid Dehydrogenase Type 1 with PET: Evaluation of the Novel Radiotracer 11C-AS2471907 in Human Brain

Single- and multiple-dose safety, tolerability and pharmacokinetics of a Novel 5HT6 receptor full antagonist (SAM-760) for the treatment of the symptoms of Alzheimer's disease in healthy young adults and elderly subjects

P4‐214: Single‐ and multiple‐dose safety, tolerability and pharmacokinetics of a Novel 5HT6 receptor full antagonist (SAM‐760) for the treatment of the symptoms of Alzheimer's disease in healthy young adults and elderly subjects

P1‐445: Early evaluation of the safety, tolerability and pharmacokinetics of a novel 5HT6 receptor full antagonist for the treatment of the symptoms of mild‐to‐moderate dementia of the Alzheimer type

Early evaluation of the safety, tolerability and pharmacokinetics of a novel 5HT6 receptor full antagonist for the treatment of the symptoms of mild-to-moderate dementia of the Alzheimer type

P3‐203: The effects of a single dose administration of SAM‐531, a 5‐HT6 antagonist, on sleep electroencephalogram (EEG) and quantitative wake EEG (qEEG) in healthy subjects

P3‐203: The effects of a single dose administration of SAM‐531, a 5‐HT 6 antagonist, on sleep electroencephalogram (EEG) and quantitative wake EEG (qEEG) in healthy subjects

Lengthening Behavior of Magnetically Controlled Growing Rods in Early-Onset Scoliosis: A Multicenter Study

The Effect of Surgeon Experience on Outcomes Following Growth Friendly Instrumentation for Early Onset Scoliosis

Growth-friendly Spinal Instrumentation in Marfan Syndrome Achieves Sustained Gains in Thoracic Height Amidst High Rates of Implant Failure

To tether or fuse? Significant equipoise remains in treatment recommendations for idiopathic scoliosis

The role of traditional growing rods in the era of magnetically controlled growing rods for the treatment of early-onset scoliosis

Low radius of curvature growth-friendly rib-based implants increase the risk of developing clinically significant proximal junctional kyphosis

Body mass index affects outcomes after vertebral body tethering surgery

Suchergebnisse filtern